According to the TCGA database, high expression of GAPDH is also a predictor of poor survival across all cancer types (PANCAN dataset; N = 11,506 patients; Fig. 5E) and in our patient cohort, GAPDH abundance was directly correlated with tumor’s glucose uptake (measured as fluorodeoxyglucose (FDG) and displayed as SUVmax values; Fig. 5F). The gene discussed is GAPDH; the disease is neoplasm.